Patents by Inventor Daniel Stephen WILKINSON

Daniel Stephen WILKINSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR IN VITRO CULTIVATION AND/OR EXPANSION OF REGULATORY T CELLS
    Publication number: 20220380728
    Abstract: FOXP3+ regulatory T cells (Tregs) can represent powerful adoptive immunotherapies for autoimmune diseases, metabolic diseases, and other chronic inflammatory diseases. The present invention is related to the ability to maintain and expand stable Treg lines and can provide insight into FOXP3+ Treg physiology and can enable feasible strategies of Treg-based immunotherapy.
    Type: Application
    Filed: June 9, 2022
    Publication date: December 1, 2022
    Inventors: Daniel Stephen Wilkinson, Mark D. Mannie
  • Compositions and methods for in vitro cultivation and/or expansion of regulatory T cells
    Patent number: 11384336
    Abstract: FOXP3+ regulatory T cells (Tregs) can represent powerful adoptive immunotherapies for autoimmune diseases, metabolic diseases, and other chronic inflammatory diseases. The present invention is related to the ability to maintain and expand stable Treg lines and can provide insight into FOXP3+ Treg physiology and can enable feasible strategies of Treg-based immunotherapy.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: July 12, 2022
    Assignee: East Carolina University
    Inventors: Daniel Stephen Wilkinson, Mark D. Mannie
  • COMPOSITIONS AND METHODS FOR IN VITRO CULTIVATION AND/OR EXPANSION OF REGULATORY T CELLS
    Publication number: 20190376031
    Abstract: FOXP3+ regulatory T cells (Tregs) can represent powerful adoptive immunotherapies for autoimmune diseases, metabolic diseases, and other chronic inflammatory diseases. The present invention is related to the ability to maintain and expand stable Treg lines and can provide insight into FOXP3+ Treg physiology and can enable feasible strategies of Treg-based immunotherapy.
    Type: Application
    Filed: December 7, 2017
    Publication date: December 12, 2019
    Inventors: Daniel Stephen WILKINSON, Mark D. MANNIE